x
Filter:
Filters applied
- Graphical Abstracts
- Adler, Douglas GRemove Adler, Douglas G filter
- July 2022 - January 2023Remove July 2022 - January 2023 filter
Graphical Abstracts
2 Results
- Systematic review and meta-analysis
Early (<4 weeks) versus standard (≥4 weeks) endoscopic drainage of pancreatic walled-off fluid collections: a systematic review and meta-analysis
Gastrointestinal EndoscopyVol. 97Issue 3p415–421.e5Published online: November 14, 2022- Daryl Ramai
- Ikponmwosa Enofe
- Smit S. Deliwala
- Daniel Mozell
- Antonio Facciorusso
- Paraskevas Gkolfakis
- and others
Cited in Scopus: 3Previous studies have demonstrated that the ideal time for drainage of walled-off pancreatic fluid collections is 4 to 6 weeks after their development. However, some pancreatic collections, notably infected pancreatic fluid collections, require earlier drainage. Nevertheless, the optimal timing of the first intervention is unclear, and consensus data are sparse. The aim of this study was to evaluate the clinical efficacy and safety of EUS-guided drainage of pancreatic fluid collections <4 weeks after development compared with ≥4 weeks after development. - Original article Clinical endoscopy
Patient-related adverse events and device failures associated with commercially available enteral or duodenal self-expanding metal stents: an analysis of the MAUDE database
Gastrointestinal EndoscopyVol. 97Issue 2p309–313Published online: October 7, 2022- Daxton Kennington
- Daryl Ramai
- Douglas G. Adler
Cited in Scopus: 0Duodenal stents are widely used to treat patients with malignant gastric outlet obstruction (MGOO), most commonly from pancreatic cancer. The WallFlex (Boston Scientific, Natick, Mass, USA) and Evolution (Cook Endoscopy, Winston-Salem, NC, USA) duodenal stents are in widespread use for treating MGOO. The objective of this study was to analyze device failures and patient-related adverse events reported to the U.S. Food and Drug Administration (FDA) for these 2 stents.